IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on June 29, 2026

Jun. 29, 2026

Beach Day API Launches Real-Time Beach and Ocean Data API for Developers

Indeterminate GlobeNewswire

Jun. 29, 2026

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

Jun. 29, 2026

NeoVolta to Participate in Virtual Fireside Chat Hosted by Needham & Company on June 30, 2026

Indeterminate GlobeNewswire

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

Jun. 29, 2026

Mondia Strengthens Gaming Offering with Ubisoft+ Partnership

Indeterminate EIN Presswire

Jun. 29, 2026

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Indeterminate GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

Indeterminate GlobeNewswire

Jun. 29, 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Indeterminate GlobeNewswire

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire

Jun. 29, 2026

TFI International publiera ses résultats du deuxième trimestre de 2026

Indeterminate GlobeNewswire

Jun. 29, 2026

TFI International to Release Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jun. 29, 2026

Nasdaq to Hold Second Quarter 2026 Investor Conference Call

Indeterminate GlobeNewswire

Jun. 29, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Indeterminate GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

Indeterminate GlobeNewswire

Jun. 29, 2026

QuickBuzz Announces Strong Momentum Following Successful Presentation at the Global Family Investment Summit

Indeterminate GlobeNewswire

Jun. 29, 2026

Lakefront Receives Transparency Notification from Madison Avenue Partners

Indeterminate GlobeNewswire

Jun. 29, 2026

Lakefront ontvangt transparantieverklaring van Madison Avenue Partners

Indeterminate GlobeNewswire

Jun. 29, 2026

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 29, 2026

Dr. Paul Stoltz Taps CYPFER to Protect His Global Intellectual Property and Leadership Platform

Indeterminate EIN Presswire

Jun. 29, 2026

Shield Introduces the First Governed AI Agent Designed to Close Compliance Alerts Autonomously

Indeterminate EIN Presswire